China NMPA Product Recall - Dental implant system

Nobel Biocare Trading (Shanghai) Co., Ltd. announced a voluntary Class II recall of dental implant systems manufactured by its parent company, Nobel Biocare AB. This action, reported to the National Medical Products Administration (NMPA) and published on August 9, 2019, was initiated due to a potential issue involving the incorrect labeling of product dimensions. The NMPA document (Index No.: JGXX-2019-10516) indicates that the manufacturer identified discrepancies in the stated specifications of the dental implant systems. While specific models, specifications, and batches are detailed in an attached 'Medical Device Recall Event Report Form,' the overarching concern is to ensure precise and accurate product information. The Class II recall classification signifies that the incorrect labeling could potentially lead to temporary or medically reversible adverse health consequences, or that the likelihood of serious adverse health consequences is remote. This proactive measure by Nobel Biocare AB underscores their commitment to regulatory compliance and patient safety in the medical device sector, emphasizing the critical importance of accurate product information for healthcare professionals and patients.